Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | SLC6A19 | Q695T7 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8900441 | 1.00 | HSD17B3 (0.65) | HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19 | |
| SCHEMBL709614 | 1.00 | HSD17B3 (0.65) | HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19 | |
| SCHEMBL699998 | 0.93 | HSD17B3 (0.59) | HSD17B3ALDH1A1NFE2L2BACE1MAPT | |
| SCHEMBL699999 | 0.93 | HSD17B3 (0.59) | HSD17B3ALDH1A1NFE2L2BACE1MAPT | |
| SCHEMBL8900696 | 0.91 | HSD17B3 (0.57) | HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19 | |
| SCHEMBL699611 | 0.91 | HSD17B3 (0.57) | HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19 | |
| SCHEMBL699610 | 0.91 | HSD17B3 (0.57) | HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19 | |
| SCHEMBL11464066 | 0.90 | HSD17B3 (0.61) | HSD17B3ALDH1A1HSD11B1SLC6A19BACE1 | |
| SCHEMBL23935305 | 0.87 | HSD17B3 (0.53) | HSD17B3ALDH1A1NFE2L2HSD11B1SLC6A19 | |
| SCHEMBL7090618 | 0.87 | ALDH1A1 (0.83) | HSD17B3ALDH1A1HSD11B1SLC6A19BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190207117-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-04 | — | — | US | disclosed |
| US-8703388-B2 | Optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2014-04-22 | — | — | US | disclosed |
| US-8507153-B2 | Compositions, optical data storage media and methods for using the optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2290651-B1 | Compositions, optical data storage media and methods for using the optical data storage media | GEN ELECTRIC (US) | 2012-10-10 | — | — | EP | disclosed |
| EP-2290408-B1 | Compositions, optical data storage media and methods for using the optical data storage media | GEN ELECTRIC (US) | 2012-08-15 | — | — | EP | disclosed |
| US-20120163145-A1 | OPTICAL DATA STORAGE MEDIA | GENERAL ELECTRIC COMPANY (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120052232-A1 | USE OF APPENDED DYES IN OPTICAL DATA STORAGE MEDIA | GENERAL ELECTRIC COMPANY (US) | 2012-03-01 | — | — | US | disclosed |
| EP-2423917-A2 | Use of chemically bonded dyes in holographic data storage media | General Electric Company (US) | 2012-02-29 | — | — | EP | disclosed |
| US-8124299-B2 | Methods for using optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2012-02-28 | — | — | US | disclosed |
| US-20110053055-A1 | COMPOSITIONS, OPTICAL DATA STORAGE MEDIA AND METHODS FOR USING THE OPTICAL DATA STORAGE MEDIA | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2290408-A1 | Compositions, optical data storage media and methods for using the optical data storage media | General Electric Company (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2290651-A1 | Compositions, optical data storage media and methods for using the optical data storage media | General Electric Company (US) | 2011-03-02 | — | — | EP | disclosed |
| US-20100302927-A1 | OPTICAL DATA STORAGE MEDIUM AND METHODS FOR USING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2010-12-02 | — | — | US | disclosed |
| US-7638663-B2 | large energy gap; use in electronic appliance with low power consumption; e.g. 3,3'-di(phenanthrene-9-yl)stilbene | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7638663-B2 | large energy gap; use in electronic appliance with low power consumption; e.g. 3,3'-di(phenanthrene-9-yl)stilbene | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7638663-B2 | large energy gap; use in electronic appliance with low power consumption; e.g. 3,3'-di(phenanthrene-9-yl)stilbene | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-20070100180-A1 | Stilbene derivative, light emitting element material, light emitting element, light emitting device and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-05-03 | — | — | US | disclosed |
| EP-0663391-B1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | HOFFMANN LA ROCHE (CH) | 1997-04-09 | — | — | EP | disclosed |
| US-5521160-A | COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY | HOFFMANN-LA ROCHE INC. (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0663391-A1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | F. HOFFMANN-LA ROCHE AG (CH) | 1995-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190207117-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MAOA, MAOB, COMT | HSD17B3 662/4885ALDH1A1 47/4885NFE2L2 491/4885 |
| US-20070100180-A1 | Stilbene derivative, light emitting element material, light emitting element, light emitting device and electronic appliance | TLL1, MT-ATP8, TLL2 | HSD17B3 2007/4885ALDH1A1 280/4885NFE2L2 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.